LADENBURG THALMANN FINANCIAL SERVICES INC. - THERAVANCE BIOPHARMA INC ownership

THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 105 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 56.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q4 2019$4,000
+33.3%
1380.0%0.00%
Q3 2019$3,000
+50.0%
1380.0%0.00%
Q2 2019$2,000
-33.3%
1380.0%0.00%
Q1 2019$3,0000.0%138
+17.9%
0.00%
Q4 2018$3,000
+200.0%
117
+588.2%
0.00%
Q3 2018$1,000170.0%0.00%
Q2 2018$0170.0%0.00%
Q1 2018$0170.0%0.00%
Q4 2017$0
-100.0%
170.0%0.00%
Q3 2017$1,0000.0%170.0%0.00%
Q2 2017$1,0000.0%170.0%0.00%
Q1 2017$1,0000.0%170.0%0.00%
Q4 2016$1,0000.0%170.0%0.00%
Q3 2016$1,000170.0%0.00%
Q2 2016$0170.0%0.00%
Q1 2016$0170.0%0.00%
Q4 2015$0170.0%0.00%
Q3 2015$017
-34.6%
0.00%
Q2 2015$0260.0%0.00%
Q1 2015$026
+52.9%
0.00%
Q4 2014$0170.0%0.00%
Q3 2014$0170.00%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
Madison Avenue Partners, LP 7,012,226$60,515,5108.59%
Irenic Capital Management LP 2,760,948$23,826,9816.76%
Newtyn Management, LLC 1,841,560$15,892,6633.92%
Weiss Asset Management LP 7,457,060$64,354,4283.81%
Park West Asset Management LLC 1,983,251$17,115,4561.57%
Baupost Group 7,419,226$64,0281.23%
Oasis Management Co Ltd. 953,254$8,226,5820.36%
Chescapmanager LLC 287,333$2,479,6840.32%
GSA CAPITAL PARTNERS LLP 325,985$2,8130.24%
Virtus ETF Advisers LLC 29,232$252,2720.15%
View complete list of THERAVANCE BIOPHARMA INC shareholders